Rivus is targeting mitochondrial uncoupling therapeutically with its lead candidate HU6
Pharmakologische Risikoanalyse zu "Injectable Peptides" (BPC-157, Melanotan) Pharmazeutische Warnung & Aufklrung | Stand: Januar 2026 Status: Beliebte Peptide wie BPC-157 oder Melanotan II haben keine Zulassung als Humanarzneimittel
Contact your healthcare provider promptly if you experience persistent or worsening pain at the injection site that does not resolve within a few hours, spreading redness or warmth extending beyond the immediate injection area, drainage or abscess formation, fever or systemic symptoms accompanying injection site reactions, or hardened nodules or lumps that persist for more than a few days
Occupational exposure of lead and cadmium on adolescent and adult workers of battery recycling and welding workshops: adverse impact on health
Immune Modulation: For individuals with autoimmune thyroid conditions, functional medicine focuses on modulating immune responses, reducing inflammation, and promoting immune tolerance to prevent further thyroid tissue damage